Article
TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy.
Cancer surveys - 1 Jan 1996
Wang X W, Harris C C
Abstract excerpt
The tumour suppressor gene product TP53 is clearly a component in several biochemical pathways, including transcription, DNA repair, genomic stability, cell cycle control and apoptosis, that are central to human carcinogenesis. TP53 is functionally inactivated by mutational, viral and cellular mechanisms in the majority of human cancers. Analysis of the spectrum of TP53 mutations provides clues to the aetiology...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
